Identification and selectivity profiling of small-molecule degraders via multi-omics approaches
{{output}}
The therapeutic modality of targeted protein degradation promises to overcome limitations of traditional pharmacology. Small-molecule degraders recruit disease-causing proteins to E3 ubiquitin ligases, prompting their ubiquitination and degradation by the prot... ...
